Italy (Co-Chair)
ESMO PRECEPTORSHIPS
State-of-the art educational courses delivered by ESMO faculty, offering an enriched and interactive learning experience
ABOUT ESMO PRECEPTORSHIPS
ESMO Preceptorships are in-person meetings combining plenary lectures and interactive case-based discussions led by a multidisciplinary faculty of 8-10 international experts. Each Preceptorship focuses on a specific malignancy or topic, giving oncologists a thorough understanding of disease management from diagnosis to treatment in line with current standards of care.
ESMO Preceptorships cover a wide range of therapy areas
BREAST CANCER
GASTROINESTINAL CANCERS
GENITOURINARY CANCERS
GYNAECOLOGICAL CANCERS
THORACIC MALIGNANCIES
SUPPORTIVE CARE
2026 ESMO PRECEPTORSHIP CALENDAR
ESMO Preceptorship on Breast Cancer 2026
16-18 JAN 2026 – MILAN, ITALY
France (Co-Chair)
ESMO Preceptorship on Metastatic Bladder & Kidney Cancer 2026
18-19 FEB 2026 – LUGANO, SWITZERLAND
UK (Co-Chair)
Spain (Co-Chair)
ESMO - The Christie Preceptorship on Lung Cancer 2026
18-19 FEB 2026 – MANCHESTER, UK
UK (Co-Chair)
UK (Co-Chair)
Spain (Co-Chair)
ESMO Preceptorship on Head & Neck Cancer 2026
13-14 MAY 2026 – LUGANO, SWITZERLAND
Netherlands (Co-Chair)
Greece (Co-Chair)
ESMO Preceptorship on Colorectal Cancer 2026
15-16 MAY 2026 – LUGANO, SWITZERLAND
Spain (Co-Chair)
Italy (Co-Chair)
ESMO Preceptorship on Small Cell Lung Cancer 2026
24-25 JUN 2026 – LISBON, PORTUGAL
Greece (Co-Chair)
Estonia (Co-Chair)
ESMO Preceptorship on Gastric Cancer 2026
26-27 JUN 2026 – LISBON, PORTUGAL
Spain (Co-Chair)
Netherlands (Co-Chair)
ESMO Preceptorship on Endometrial Cancer 2026
1-2 JUL 2026 – LISBON, PORTUGAL
Switzerland (Co-Chair)
Germany (Co-Chair)
ESMO Preceptorship on Ovarian Cancer 2026
8-9 JUL 2026 – MUNICH, GERMANY
Germany (Co-Chair)
Spain (Co-Chair)
ESMO Preceptorship on Breast Cancer 2026
10-11 JUL 2026 – MUNICH, GERMANY
Germany (Co-Chair)
UK (Co-Chair)
ESMO Preceptorship on Tumour Agnostic and Cancer of Unknown Primary 2026
18-19 SEP 2026 – ZURICH, SWITZERLAND
UK (Co-Chair)
Germany (Co-Chair)
ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026
29-30 SEP – LUGANO, SWITZERLAND
Germany (Co-Chair)
Denmark (Co-Chair)
ESMO Preceptorship on Colorectal Cancer 2026
1-2 OCT 2026 – LUGANO, SWITZERLAND
Germany (Co-Chair)
UK (Co-Chair)
ESMO Preceptorship on Prostate Cancer 2026
DATE TBC – COUNTRY TBC
TBC (Co-Chair)
TBC (Co-Chair)
ESMO Preceptorship on NSCLC 2026
JAN 2027 – HELSINKI, FINLAND
TBC (Co-Chair)
TBC (Co-Chair)
ESMO PRECEPTORSHIP METRICS 2025
594
57
58.7%
121
66
BENEFITS FOR OUR PARTNERS
FUNDING OPTIONS
Support type |
Funding amount per sponsor (EUR) |
|---|---|
| 100% funding (single sponsor) | € 162,000 |
| 50% funding (2 sponsors) | € 81,000 |
Support for ESMO-The Christie Preceptorship on Lung Cancer |
Funding amount per sponsor (EUR) |
|---|---|
| 25% funding (4 sponsors) | € 75,000 |


